Revenue Performance - Full year 2025 revenue reached $90.9 million, a 3.5% increase from $86.9 million in 2024[1] - Fourth quarter 2025 revenue was $48.3 million, up 21.6% from $39.7 million in Q4 2024, and up significantly from $6.3 million in Q3 2025[1][5] - Total revenue for the year ended December 31, 2025, was $90,907,000, representing an increase of 3.4% from $86,935,000 in 2024[31] - For the three months ended December 31, 2025, revenue was $48,278,000, an increase from $39,729,000 in the same period of 2024[31] Profitability - Gross profit for the full year was $54.4 million, with a gross margin of 59.9%, down from 67.1% in 2024[12][13] - Gross profit decreased to $54,415,000 in 2025, down 6.5% from $58,317,000 in 2024[31] - Operating loss for the year was $(28.8) million, compared to $(17.4) million in 2024[13] - Net loss for 2025 was $(4.1) million, an improvement from $(38.7) million in 2024[14] - Net loss for the year ended December 31, 2025, was $4,104,000, a significant improvement compared to a net loss of $38,694,000 in 2024[31] - The company reported a net loss margin of (4.5)% for the year ended December 31, 2025, compared to (44.5)% in 2024, indicating improved profitability[33] Expenses and Costs - Total operating expenses increased to $83,180,000 in 2025, up 9.3% from $75,750,000 in 2024, primarily due to higher research and development costs[31] - Adjusted EBITDA for 2025 was $5.7 million, down from $33.7 million in 2024[16] - Adjusted EBITDA for the year was $5,658,000, down from $33,690,000 in 2024, reflecting changes in operational efficiency[33] Financial Position - Cash position as of December 31, 2025, was $74.4 million[17] - Total current assets increased to $106,476,000 in 2025, compared to $42,595,000 in 2024, indicating improved liquidity[28] - Total liabilities decreased to $34,947,000 in 2025 from $152,269,000 in 2024, showing a significant reduction in financial obligations[29] - Cash reserves rose to $74,358,000 in 2025, up from $20,741,000 in 2024, enhancing the company's financial stability[28] Future Outlook - The company expects 2026 revenue growth of 15% to 25% year-over-year, supported by a backlog of approximately $150 million as of March 31, 2026[18][19] - The company completed its first U.S.-manufactured RQ-35 Heidrun ISR drones and is targeting Blue UAS certification in the first half of 2026[11]

FOR IMMEDIATE RELEASE McCORMICK REPORTS STRONG FIRST QUARTER PERFORMANCE AND REAFFIRMS 2026 OUTLOOK Sales Metrics | | | | First Ouarter 2026 | | | | | --- | --- | --- | --- | --- | --- | --- | | | As | | Organic(1) | | Acquisition | Constant | | | Reported | | | | | Currency | | | % Change | Volume/ Mix | Price | % Change | % Change | % Change | | Total Net Sales | 16.7 % | (0.7)% | 1.9 % | 1.2 % | 12.4 % | 13.6 % | | Total Consumer | 24.5 % | (0.4)% | 2.2 % | 1.8 % | 19.8 % | 21.6 % | | Americas | 30.4 % | ...

FOR IMMEDIATE RELEASE HUNT VALLEY, Md., March 31, 2026 - McCormick & Company, Incorporated (NYSE:MKC), a global leader in flavor, today reported financial results for the first quarter ended February 28, 2026 and reaffirmed its outlook for fiscal 2026. Chairman, President, and CEO's Remarks Brendan M. Foley, Chairman, President, and CEO, stated, "We are pleased to begin the year with first quarter results that demonstrate the strength and resilience of our business. We delivered strong growth in sales, adju ...

Stock Split and Corporate Changes - The Company executed a reverse stock split at a ratio of 1-for-12, reducing authorized shares from 300 million to 25 million and outstanding shares from 151.7 million to 12.6 million [12][14]. - The reverse stock split and name change to "Meridian Holdings Inc." became effective on March 3, 2026 [13]. - No fractional shares were issued; stockholders entitled to fractional shares received cash based on the closing sale price prior to the effective time [14]. - The conversion ratio for preferred stock and the number of shares issuable upon exercise of stock options were adjusted proportionately in line with the 1-for-12 split [16]. - The exercise price for outstanding stock options and warrants was increased in inverse proportion to the split ratio, maintaining the aggregate exercise price [16]. - The effects of the reverse split and name change have been retroactively reflected throughout the report [17]. Financing and Growth - The Company anticipates the need for significant additional financing to support growth, acquisitions, and operational expansion [20]. - The Company requires significant additional financing to grow and expand operations, complete acquisitions, and pay post-closing amounts related to the MeridianBet Group acquisition [20]. Risks and Uncertainties - Risks include potential dilution from the conversion of outstanding debt and preferred stock, as well as challenges in completing acquisitions [20]. - Risks include dilution from the conversion of outstanding debt, preferred stock, and warrants, as well as potential disruptions caused by acquisitions [20]. - The Company faces risks related to gaming fraud, user cheating, and cybersecurity threats [21]. - The Company faces risks associated with gaming fraud, user cheating, and cyber-attacks [21]. - There are concerns regarding systems failures and technology infrastructure that the Company's programs rely on, including cybersecurity and hacking risks [22]. - Forward-looking statements are subject to various risks and uncertainties that may cause actual results to differ materially from projections [19][24]. - Forward-looking statements are inherently uncertain and should not be relied upon excessively by investors [23]. - The Company has no obligation to update or revise forward-looking statements unless required by law [24].

Enrollment and Revenue - For the fiscal year ended December 31, 2025, the company had 4,127 students enrolled, with 57% in portfolio training programs[23] - Net revenues for the fiscal years ended December 31 were RMB221.6 million in 2023, RMB268.1 million in 2024, and RMB268.1 million ($38.3 million) in 2025[23] - Net revenues for 2024 reached RMB 268,060,162, a 21% increase from RMB 221,618,968 in 2023[72] - The net loss for 2024 was RMB 36,097,872, slightly improved from a net loss of RMB 33,710,541 in 2023[72] - The company’s total current assets in 2024 were RMB 111,367,124, a decrease from RMB 66,639,674 in 2025[76] Financial Performance - For the fiscal year ended December 31, 2025, the Company reported net revenues of RMB 268.1 million, with total costs and expenses amounting to RMB 332.4 million, resulting in a net loss of RMB 48.0 million[70] - The Company incurred a goodwill impairment of RMB 33.9 million in the fiscal year ended December 31, 2025[70] - Total cost and expenses for 2024 were RMB 311,279,249, compared to RMB 263,145,737 in 2023, reflecting an 18% increase[72] - The company reported a significant investment loss of RMB 29,233,857 in 2024, compared to a loss of RMB 28,469,235 in 2023[72] Regulatory Environment - The variable interest entity (VIE) structure involves unique risks, including potential disallowance by PRC regulatory authorities, which could materially affect operations and the value of ADSs[24] - The company is subject to complex and evolving PRC laws and regulations, which could adversely affect its business operations and reputation[25] - The Company believes it is not required to obtain permission or approval from the CSRC for its listing on Nasdaq, but future compliance with the Crackdown Opinions remains uncertain[45] - The PRC regulatory environment for private education institutions is evolving, with new requirements for operating permits for non-academic after-school tutoring institutions, particularly in provinces like Guangdong and Liaoning[172] Business Operations - The company is exploring acquisition opportunities in the international education sector to broaden its service spectrum[22] - The company has established 19 training centers in China as of March 20, 2026, with the first center opened in 2012[113] - The company is focusing on developing and expanding its small-sized class model and online-merge-offline model to improve profit margins[115] - The company has made strategic investments in complementary businesses, but past investments have been fully impaired, raising concerns about future acquisitions[122] Cash Flow and Dividends - The Company did not distribute any dividends to its shareholders for the fiscal years ended December 31, 2023, 2024, and 2025, and future dividend payments will depend on various factors including operations and earnings[64] - The Company faces restrictions on cash transfers between entities and to U.S. investors, which may impact its ability to pay dividends or service debt[66] - Under PRC law, dividends from PRC subsidiaries can only be paid out of accumulated after-tax profits, which may limit the Company's ability to distribute earnings[157] Risks and Challenges - The company may face challenges in generating sufficient net income to sustain continued expansion, which could impact financial performance[97] - A decline in market acceptance or growth of the company's products and services could lead to decreased revenues, particularly in creative arts-related international education services[104] - The company faces increasing competition from both established brands and new entrants, which may negatively affect revenues and market share[128] - The company may experience declines in student enrollment due to geopolitical uncertainties and economic slowdowns affecting international study[119] Compliance and Cybersecurity - The evolving data security regulations in China, including the Cyber Security Law and the Personal Information Protection Law, impose significant obligations on network operators regarding the protection of personal information[177] - The company has implemented various security measures to protect user information but cannot guarantee that these measures will be sufficient to prevent data breaches[177] - The company has not received any inquiries, notices, warnings, sanctions, or regulatory objections from the national cyberspace authorities regarding personal information protection compliance[181] Corporate Structure - The Company adopts a holding company structure and may rely on dividends and distributions from its PRC subsidiaries for cash requirements[51] - The Company is classified as a Cayman Islands holding company, with nearly all business operations conducted in mainland China, which may classify it as an "indirect issuance of securities overseas" under new regulations[153] - The VIE is 90% owned by the Chairman and 10% by the President, and the Company has contractual arrangements to direct the activities of the VIE[218] Audit and Accounting - The company appointed Audit Alliance LLP as its new independent registered public accounting firm for the fiscal year ending December 31, 2023[86] - The PCAOB has secured complete access to inspect and investigate registered public accounting firms in mainland China and Hong Kong, which interrupted the calculation of the consecutive period to trigger trade prohibition for the Company[204] - The Company is subject to potential delisting of its ADSs if the PCAOB cannot conduct full inspections of its auditor in the future, which may adversely affect the value of investments[205]

Financial Performance - Total revenue for Q4 2025 was $16.0 million, a decrease of 4% from Q4 2024, primarily due to a $2.6 million decline in system revenue, partially offset by a $1.8 million increase in revenue from higher worldwide procedure volume[3]. - Total revenue for Q4 2025 was $16,025,000, a decrease of 4.23% from $16,731,000 in Q4 2024[26]. - Recurring revenue for the full year 2025 exceeded $46.3 million, reflecting a 15% increase over 2024, with 79% of total revenue for both Q4 and the full year coming from recurring sources[2][6]. - Product revenue for the twelve months ended December 31, 2025, was $45,928,000, an increase of 11.00% compared to $41,065,000 in 2024[26]. - The net loss for Q4 2025 was $1.5 million, or ($0.12) per share, a significant improvement from a net loss of $18.7 million, or ($1.61) per share, in Q4 2024[9]. - Net loss for Q4 2025 was $1,458,000, compared to a net loss of $18,702,000 in Q4 2024[26]. - Adjusted EBITDA for Q4 2025 was $0.6 million, compared to $0.5 million in Q4 2024, indicating a positive trend in operational performance[10][22]. - Adjusted EBITDA for Q4 2025 was $595,000, up from $478,000 in Q4 2024[24]. Operational Metrics - In Q4 2025, LENSAR placed 15 ALLY Robotic Cataract Laser Systems, increasing the installed base to approximately 200 systems, a 48% growth compared to the end of 2024[4]. - Worldwide procedure volume increased by approximately 20% in Q4 2025 compared to Q4 2024, with a total of 206,014 procedures performed in 2025, up from 169,506 in 2024[3][6]. - The total combined installed base of LENSAR Laser Systems and ALLY Systems reached approximately 435 systems as of December 31, 2025, representing a 13% increase from the previous year[5]. - The company has a backlog of 13 ALLY Systems pending installation as of December 31, 2025, indicating ongoing demand for its products[4]. Expenses and Liabilities - Selling, general and administrative expenses rose to $10.3 million in Q4 2025, a 51% increase from $6.8 million in Q4 2024, largely due to acquisition-related costs[6][8]. - Selling, general and administrative expenses for the twelve months ended December 31, 2025, were $45,157,000, an increase of 70.50% from $26,488,000 in 2024[26]. - Research and development expenses for the twelve months ended December 31, 2025, were $5,622,000, slightly up from $5,329,000 in 2024[26]. - Total current assets increased to $46,771,000 in 2025 from $41,979,000 in 2024, reflecting a growth of 11.00%[28]. - Total liabilities rose significantly to $83,665,000 in 2025, compared to $47,651,000 in 2024, marking a 75.61% increase[28]. - Cash and cash equivalents decreased to $12,974,000 in 2025 from $16,263,000 in 2024, a decline of 20.00%[28]. - As of December 31, 2025, LENSAR had cash, cash equivalents, and investments totaling $18.0 million, down from $22.5 million at the end of 2024[11].

Product Development - NeOnc is developing two lead products: NEO100, which is in Phase IIa trials, and NEO212, which has received IND approval and is set to begin clinical trials in Q4 2023[22][26]. - The Phase IIa trial for NEO100 has expanded eligibility to include patients with recurrent Grade III IDH1/2 mutant astrocytomas, increasing the potential enrollment pool significantly[24]. - NEO212 has established a recommended Phase 2 dose of 610 mg, with preliminary observations suggesting anti-tumor activity in heavily pretreated patients[27]. - The ongoing Phase IIa trials aim to confirm dosing requirements and assess the drug's performance in a larger patient population[52]. - The company is also conducting a Phase I/II trial for oral NEO212, targeting various solid tumors with brain metastases[69]. - NEO212 has received FDA approval for oral administration in 2023, enabling Phase I/IIa clinical trials focusing on patients with intracranial malignancies[79]. Clinical Trial Results - In the Phase I trial of NEO100, 21% of patients showed radiographic responses, exceeding the historical response rates of <8% for recurrent high-grade gliomas[25]. - NEO100's Phase I trial demonstrated that 37% of patients were alive two years after treatment, compared to an average life expectancy of six months for recurrent glioblastoma patients[35]. - In a Phase I trial, 25% of patients with recurrent glioblastoma survived for at least 4 years, indicating preliminary signs of activity for NEO100[41][44]. - Among 12 patients in the Phase I trial, 55% survived more than one year, and 33% survived over two years[44]. - The Phase IIa study for NEO100 includes 25 patients with recurrent glioblastoma and aims to evaluate progression-free survival at six months[53][54]. - In a Phase I clinical trial, intranasal NEO100 demonstrated a progression-free survival (PFS-6) rate of 33% and an overall survival (OS-12) rate of 55% among 12 patients[100]. - The ongoing Phase 1/2a study of intranasal NEO100 has enrolled 25 patients, with 24% showing radiographic responses and 44% achieving progression-free survival at six months[103]. Drug Delivery Methods - NEO100 is being investigated for its potential to bypass the blood-brain barrier (BBB) for drug delivery, with proof of concept observed in animal models but not yet in humans[40]. - NEO100's intranasal delivery method allows for convenient administration at home, avoiding invasive procedures[51]. - NEO100's intranasal delivery method allows for direct brain access, potentially avoiding the blood-brain barrier and reducing systemic side effects[86]. - The company is exploring three drug delivery pathways using NEO100, with intranasal delivery being the only one currently in clinical testing[83]. - Intra-arterial delivery of NEO100 demonstrated the ability to open the blood-brain barrier, allowing therapeutic agents to enter the brain in mouse models[119]. Market Potential - The global CNS treatment market is projected to grow at a CAGR of 8.6% to reach $267.6 billion by 2034, while the brain tumor drug market is expected to grow at a CAGR of 9.8% to reach $4.6 billion by 2032[91]. - The GBM drug market is anticipated to grow at a CAGR of 9.8% to $4.4 billion by 2023, driven by an increasing geriatric population and rising incidence rates[92]. - The average life expectancy for patients with newly-diagnosed glioblastoma is currently only 15 months, highlighting the urgent need for effective treatments like NEO212[137]. Regulatory and Compliance - The company has no commercial products or sales infrastructure, and must conduct clinical trials to obtain regulatory approvals[28]. - The FDA regulates the approval process for new drug products, requiring substantial time and financial resources for compliance with testing and manufacturing standards[183][184]. - The company must submit a new drug application (NDA) to the FDA, which includes evidence of safety and efficacy from clinical trials, before marketing any new drug product[189]. - The FDA requires extensive monitoring and auditing of clinical activities, with annual progress reports detailing clinical trial results submitted to the FDA[192]. - Manufacturers must comply with cGMP regulations, including quality control and assurance, to maintain product safety and efficacy[216]. Intellectual Property - The company holds exclusive rights to 28 issued patents and 14 pending patent applications in the U.S., with a total of 65 issued patents and 28 pending applications internationally[147]. - The company has filed multiple patent applications for its product candidates, including NEO100 and NEO212, with expiration dates ranging from 2031 to 2038[150]. - The company is responsible for all reasonable patent expenses incurred by USC for filing, prosecution, and maintenance of the licensed patents[157]. - The patent prosecution process is complex and may require narrowing claims, which could limit the scope of patent protection[153]. Financial Obligations - The company has a litigation settlement payable of $4 million to OEP, which is recorded in the consolidated balance sheets as of December 31, 2025 and 2024[169]. - The company has settled a dispute with Fox Infused for $600,000, payable within 5 business days of the closing date of the initial public offering, with accumulated interest of 10% per annum for any default[179]. - The company must pay USC $230,000 by March 31, 2024, to satisfy prior unpaid sublicense issue royalties and annual maintenance royalties due for sublicensees[166]. Competitive Landscape - The competitive landscape for CNS treatments includes established players like Pfizer, Roche, and Novartis, as well as emerging therapies such as gene therapies and biologics[138][141]. - The company is investigating additional proprietary chemotherapy agents that have shown positive effects in laboratory tests for various cancers, including NEO212 for brain cancer[149]. Future Strategies - Future growth strategies include potential commercial launch of NEO100 following FDA approval and exploration of pediatric indications for NEO100[149]. - The company aims to change the cancer therapeutic landscape by developing novel drug delivery methods combined with new drug candidates[94].

Market Dependence and Competition - The company is highly dependent on independent distributors for sales, which may impact profitability if they do not succeed in selling products[44]. - The company faces intense competition in the cybersecurity and application delivery solutions market, which may lead to loss of market share if not managed effectively[52]. - Competition for qualified personnel in the cybersecurity domain is intense, which may hinder the company's ability to attract and retain talent[51]. - The cybersecurity market is undergoing rapid technological shifts due to accelerated Digital Transformation and Generative/Agentic AI, necessitating the development of new solutions and enhancements to remain competitive[55]. - The cybersecurity and application delivery solutions market is rapidly evolving, and any slowdown in growth could reduce the company's addressable market and sales[88]. Financial Performance and Risks - The company has incurred net losses in the past and may continue to do so in the future, particularly if market conditions do not improve[36]. - There is a risk of component shortages due to manufacturing issues or supply chain disruptions, which could adversely affect sales and profitability[45]. - The global market and economic conditions, including geopolitical tensions and inflation, pose risks that could materially affect the company's operations and financial results[43]. - In 2025, the company reported an operating income of $11.4 million, while it faced operating losses of $3.9 million in 2024 and $31.7 million in 2023, with a net loss of $21.6 million in 2023[86]. - The company may face significant litigation costs related to intellectual property rights, which could divert management resources and impact operating results[99]. Regulatory and Compliance Challenges - The company may face regulatory, litigation, and reputational risks associated with the use of AI technologies, impacting its financial condition[36]. - The regulatory framework for AI technologies is rapidly evolving, with potential new laws and regulations that could increase operating expenses and affect business operations[74]. - The company is subject to stringent and evolving laws related to data privacy and security, which may require significant resources for compliance and could lead to substantial costs[100]. - The company is subject to various data privacy and protection regulations, including GDPR in the EEA and UK DP Laws, which impose strict compliance requirements for handling personal data[203]. - The DORA regulations, effective January 2025, will require additional security and governance controls for financial institutions and their service providers, impacting compliance costs[204]. Research and Development - The company must develop new solutions and enhance existing ones to remain competitive in a rapidly evolving market[36]. - Future success will depend on accurately identifying market trends, anticipating customer needs, and investing in research and development, including acquisitions of complementary solutions[56]. - The company invests significantly in research and development to maintain technological expertise and introduce new commercially viable solutions[188]. - The company has approximately $75.8 million in intangible assets, which are subject to impairment testing that could lead to significant charges in the future[107]. - Research and development grants deducted from expenses amounted to $0.3 million, $0.04 million, and $0.4 million for the years ended December 31, 2025, 2024, and 2023, respectively[218]. Supply Chain and Operational Risks - Any disruptions in the supply chain, including those caused by natural disasters or cyber-attacks, could have a material adverse effect on the company's business[49]. - The company has implemented contingency measures to mitigate potential disruptions to operations and supply chain due to regional security risks[193]. - The company may pursue acquisitions or investments that could disrupt operations and harm financial condition, with past acquisitions leading to liabilities and costs[91][92]. - The company is actively monitoring its contractual relationships to ensure compliance with applicable sanctions, which may lead to significant costs and operational challenges[122]. - The company completed the migration of its on-premises data warehouse to a cloud-based environment in 2025, exposing it to potential cybersecurity risks[115]. Market Expansion and Customer Base - Approximately 59% of total sales in 2025 came from markets outside North, Central, and South America, compared to 57% in 2024[85]. - In 2025, approximately 41% of revenues were generated from sales in North, Central, and South America, 37% in Europe, the Middle East, and Africa (EMEA), and 22% in Asia-Pacific[184]. - The company aims to expand its market footprint by collaborating with leading partners such as Cisco and Check Point to access large customers[181]. - The company offers a range of cloud-based security-as-a-service subscriptions, on-premises hardware and software products, and managed services[166]. - The company has established new cloud security service centers in multiple locations, including Tel Aviv, Bogota, Chennai, Mumbai, Nairobi, and Lima, contributing to a global network of over 50 centers with a total attack mitigation capacity exceeding 15Tbps[176]. Corporate Governance and Social Responsibility - The company has established a corporate governance framework to align with stakeholder interests and promote ethical behavior across decision-making processes[224]. - The company emphasizes ethical business conduct, requiring compliance with laws and avoiding conflicts of interest among all employees and directors[225]. - The company aims to promote a diverse and motivated workforce, ensuring a work environment free from discrimination and harassment[222]. - The organizational structure includes a wholly owned subsidiary, Radware Inc., in the United States, and several other subsidiaries worldwide, focusing on local sales and marketing[226]. - The company maintains a zero tolerance policy for harassment and discrimination, ensuring a safe work environment for all employees[225].

Financial Performance - TCE income – Shipping for the year ended 31 December 2025 was US$708,974,000, an increase from US$608,196,000 in 2024, but a decrease from US$797,495,000 in 2023[30] - TCE income – Shipping per calendar day (total) decreased to US$43.2 in 2025 from US$47.4 in 2024 and US$61.6 in 2023[30] - Adjusted free cash flow for 2025 was US$510,254,000, significantly higher than US$211,582,000 in 2024, but lower than US$564,272,000 in 2023[42] - The Group's net cash from operating activities for 2025 was US$567,403,000, down from US$749,144,000 in 2024[42] - The Group's operating profit for the year ended 31 December 2025 was US$348,048,000, a decrease from US$433,689,000 in 2024 and US$523,729,000 in 2023[46] - The average total shareholders' equity increased to US$1,931,524,000 in 2025 from US$1,761,827,000 in 2024 and US$1,591,375,000 in 2023[46] - The Group's Return on Capital Employed (ROCE) decreased to 11.6% in 2025 from 16.5% in 2024 and 23.5% in 2023[46] Revenue Sources - Revenue from Product Services includes trading activities and net derivative gains, contributing to the overall financial performance of the Group[21] - In 2025, 69.3% of the Group's revenue from LPG shipping was generated based on current market levels (spot prices), while 30.7% was from time charters[68] - Product Services' profitability is heavily dependent on identifying and exploiting arbitrage opportunities in the LPG market, which can be volatile and fragmented[167] Operational Costs - Vessel operating expenses increased to US$126,299,000 in 2025 from US$84,984,000 in 2024 and US$82,192,000 in 2023[38] - The Group's bunker fuel expenses accounted for 49% of total voyage expenses for the year ended December 31, 2025, and 47% for 2024[96] - A 50% increase in bunker fuel prices could lower the Group's profit after tax by approximately US$85.0 million for 2025 and US$90.7 million for 2024[96] Market Risks - The Group's financial performance is subject to risks including geopolitical events, trade disputes, and fluctuations in LPG freight rates[66] - The Group's operations are impacted by the highly cyclical nature of the LPG shipping industry, which may lead to volatility in results[66] - The Group's business may be adversely affected by increased protectionism and trade disputes, which could lead to a decline in global trade and shipping demand[73] - An oversupply of LPG shipping capacity could lead to a decline in freight rates, adversely affecting the Group's financial condition and results of operations[91] - Climate change presents both immediate and long-term risks to the Group's business, potentially leading to increased operational costs and regulatory challenges[87] Regulatory and Compliance Risks - Changes in governmental regulations could adversely affect the Group's ability to trade and may result in loss of revenue and increased costs[104] - The Group's operations are subject to international competition rules, which may hinder expansion plans and require regulatory approvals[107] - The Group anticipates substantial expenses for compliance with environmental regulations, including modifications to vessels and operational changes, which could adversely affect financial results[116] Customer Dependency - The Group's top five shipping customers contribute a significant portion of its LPG revenue, and the loss of any major customer could lead to substantial revenue loss[67] - The company derives 40% of its revenue from its top five shipping customers, highlighting the risk of significant revenue loss if any major customer defaults[131] Financing and Debt - The Group's existing credit facilities impose financial covenants that may limit its ability to pay dividends, incur additional indebtedness, or engage in certain corporate activities[193] - The Group's debt levels could limit its flexibility to obtain additional financing and pursue business opportunities, potentially impacting its operating performance[195] - The Group's ability to service its debt will depend on its future financial and operating performance, which may be affected by prevailing economic conditions[195] Internal Controls and Governance - A material weakness in the Group's internal control over financial reporting was identified, related to insufficient personnel with knowledge of SEC reporting requirements[201] - The Group successfully remediated previously identified material weaknesses in internal controls over financial reporting as of December 31, 2025[203] - The Group's ability to maintain effective internal controls is critical to avoid material misstatements in financial statements, which could impact shareholder confidence and access to capital markets[205] Operational Challenges - The Group may incur unexpected costs and off-hire periods due to vessel damage or operational issues, negatively impacting revenue and cash flow[145] - Drydocking of vessels requires significant capital expenditures and can lead to loss of revenue during off-hire periods, affecting profitability[146] - The Group relies on third-party managers for technical management of its fleet, which poses risks if these managers fail to perform[149] Market Competition - The competitive landscape in LPG shipping is intense, with substantial competition from companies with greater financial resources, which may impact the company's ability to secure profitable contracts[120] - The company’s lack of diversification in the LPG transportation sector makes it vulnerable to adverse developments in this market, potentially affecting financial stability[125] Taxation - The Group faces risks related to tax disputes and changes in tax laws, which could lead to higher effective tax rates and adversely affect earnings and cash flows[175] - The implementation of OECD's BEPS 2.0 proposals may require the Group to file additional tax returns and could increase effective tax rates depending on jurisdictional interpretations[180]

Financial Performance - The company incurred a net loss of $77.3 million and $93.3 million for the years ended December 31, 2025, and December 31, 2024, respectively, with net cash used in operating activities amounting to $55.1 million for the year ended December 31, 2025 [74]. - The company anticipates continuing to incur significant losses and negative cash flows from operating activities in the future, raising substantial doubt about its ability to continue as a going concern [77][78]. - The company may not achieve or sustain profitability without generating increased revenue levels, and higher operating expenses could hinder profitability [106]. - The company’s operating results may fluctuate significantly, and past performance may not be indicative of future results [88]. - In 2025, the company recorded a non-cash impairment charge of $3.5 million related to long-lived assets associated with certain retail stores due to operating cash flow losses and store closures [131]. Capital Requirements and Funding - The company requires additional capital to support business growth, which may not be available or could result in dilution of existing stockholders [79]. - The company’s future capital requirements will depend on factors such as revenue growth rate, cash burn rate, and overall economic conditions [79]. - As of December 31, 2025, the company sold 386,289 shares of its common stock under an ATM Sales Agreement for aggregate gross proceeds of $1.7 million [80]. - The company entered into a secured $50.0 million revolving credit agreement on June 30, 2025, which imposes significant operating and financial restrictions [95]. Market and Competitive Landscape - The company operates in a highly competitive market, and its ability to maintain or grow market share may be adversely affected by competitors with greater resources [72]. - The company faces significant competition in the footwear and apparel market, which may lead to pricing pressures and reduced profit margins [109]. - Economic uncertainty in key markets may adversely affect consumer demand for discretionary items, impacting sales of the company's products [100]. - The company faces risks related to its reliance on third-party distributors for international sales, which may negatively impact operating results and brand value [72]. Business Strategy and Operations - The company’s success depends on attracting new customers and retaining existing ones, with a significant portion of net revenue generated from existing customers [86][87]. - The company transitioned its operations in South Korea, Canada, New Zealand, and China to a distributor model, resulting in losses on the sale of certain net assets [92]. - The transition to a distributor model has been implemented in all markets except the United Kingdom, with agreements established in Canada, South Korea, Japan, Australasia, and China [97]. - The company is focused on using sustainable materials, which may increase costs and impact revenue growth [72]. - The company emphasizes sustainable materials and environmentally friendly manufacturing processes, which may increase costs and hinder revenue growth [118]. Supply Chain and Production Risks - Supply chain disruptions could arise from reliance on third-party suppliers, which may not meet production requirements or quality standards, adversely affecting revenue [166][171]. - The operations of suppliers located outside the United States are subject to risks such as political unrest and economic instability, which could disrupt production and trade [174][175]. - The company transitioned all new footwear manufacturing to a single manufacturer in Vietnam in 2023, but diversified across multiple manufacturers in 2025 to reduce reliance on any single source [130]. - Shipping and delivery disruptions could negatively impact customer satisfaction and financial results, with potential delays leading to lost sales [176]. Regulatory and Compliance Issues - The company is subject to potential regulatory investigations and liabilities related to its use of social media for marketing, which could adversely affect its financial condition [144]. - Compliance with various privacy laws, such as the California Consumer Privacy Act (CCPA) and the California Privacy Rights Act (CPRA), may increase compliance costs and potential liabilities for the company [205]. - The company is subject to the General Data Protection Regulation (GDPR) in the European Economic Area, which imposes strict data protection compliance requirements, including potential fines of up to 20 million euros or 4% of total global annual turnover for breaches [214]. - Changes in U.S. and global trade policy, including tariffs, could increase product costs and disrupt the supply chain, adversely affecting financial results [110]. Human Resources and Corporate Culture - Employee attrition was experienced at all levels during the year ended December 31, 2025, and the company anticipates this trend may continue, impacting hiring and morale [153]. - The company’s corporate culture, rooted in innovation and sustainability, is at risk due to challenges in attracting and retaining key personnel who share these values [155]. - The company’s ability to attract and retain talent is critical for growth, and competition for skilled personnel is intense, particularly in Northern California [152]. Legal and Litigation Risks - The company is currently involved in litigation related to securities class action lawsuits, which could result in significant legal fees and impact its financial condition [233]. - The company faces risks related to intellectual property protection, particularly in countries with limited enforcement, which could weaken brand value and competitive position [180]. - The company anticipates needing to devote significant additional resources to comply with evolving privacy and data protection laws, which may impact its revenue and operational efficiency [204]. Stock and Market Dynamics - The market price of the company’s Class A common stock has experienced volatility, which may result in substantial losses for investors [241]. - The company received notice from Nasdaq for non-compliance with listing requirements due to its stock price falling below $1.00 per share [246]. - The company executed a 1-for-20 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement [247]. - Additional stock issuances may lead to significant dilution for existing stockholders, particularly through equity-based compensation and other capital-raising efforts [256].